164 related articles for article (PubMed ID: 2459682)
1. Treatment with antiandrogens induces an androgen-repressed gene in the rat ventral prostate.
Léger JG; Le Guellec R; Tenniswood MP
Prostate; 1988; 13(2):131-42. PubMed ID: 2459682
[TBL] [Abstract][Full Text] [Related]
2. Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.
Rennie PS; Bruchovsky N; Goldenberg SL; Lawson D; Fletcher T; Foekens JA
J Urol; 1988 Jun; 139(6):1337-42. PubMed ID: 2967378
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyproterone acetate in comparison to flutamide and megestrol acetate on the ventral prostate, seminal vesicle, and adrenal glands of adult male rats.
el Etreby MF; Habenicht UF; Louton T; Nishino Y; Schröder HG
Prostate; 1987; 11(4):361-75. PubMed ID: 2960960
[TBL] [Abstract][Full Text] [Related]
4. Effect of antiandrogens on some key enzymes of glycolysis in epididymis and ventral prostate of rat.
Gupta G; Srivastava A; Setty BS
Indian J Exp Biol; 1989 Apr; 27(4):324-8. PubMed ID: 2530166
[TBL] [Abstract][Full Text] [Related]
5. Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostate.
Labrie C; Simard J; Zhao HF; Pelletier G; Labrie F
Mol Cell Endocrinol; 1990 Jan; 68(2-3):169-79. PubMed ID: 2138099
[TBL] [Abstract][Full Text] [Related]
6. Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection.
Nguyen TV; Yao M; Pike CJ
Endocrinology; 2007 Jun; 148(6):2936-43. PubMed ID: 17347309
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyproterone acetate in comparison to flutamide on the ventral prostate of adult male castrated Copenhagen-Fisher rats and on Dunning R-3327 H tumors.
Donn F; Becker H; Klosterhalfen H; Klein H
Andrologia; 1989; 21(5):462-7. PubMed ID: 2530921
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific action of antiandrogens on androgen induced changes in hepatic microsomal 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase activity in the rat.
Lax ER; Schriefers H
Acta Endocrinol (Copenh); 1981 Oct; 98(2):261-6. PubMed ID: 6457494
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Labrie C; Cusan L; Plante M; Lapointe S; Labrie F
J Steroid Biochem; 1987 Oct; 28(4):379-84. PubMed ID: 2444770
[TBL] [Abstract][Full Text] [Related]
10. The effect of antiandrogens and stilboestrol on the cytosol receptor in rat prostate.
Ghanadian R; Smith CB; Williams G; Chisholm GD
Br J Urol; 1977; 49(7):695-700. PubMed ID: 74269
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetate.
Poyet P; Labrie F
Mol Cell Endocrinol; 1985 Oct; 42(3):283-8. PubMed ID: 3930312
[TBL] [Abstract][Full Text] [Related]
12. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism.
Kelce WR; Lambright CR; Gray LE; Roberts KP
Toxicol Appl Pharmacol; 1997 Jan; 142(1):192-200. PubMed ID: 9007049
[TBL] [Abstract][Full Text] [Related]
13. [A study of the androgenic activity of anti-androgen].
Imai K; Watanabe K; Takahashi O; Shimizu N; Nakata S; Kawashima K; Suzuki T; Yamanaka H
Nihon Naibunpi Gakkai Zasshi; 1990 Jun; 66(6):597-606. PubMed ID: 1696915
[TBL] [Abstract][Full Text] [Related]
14. Anti-androgens do not alter androgen-dependent characteristics of acid phosphatase in the rat ventral prostate.
Tenniswood M; Abrahams P; Bird C; Clark A
Mol Cell Endocrinol; 1984 Sep; 37(2):153-8. PubMed ID: 6489601
[TBL] [Abstract][Full Text] [Related]
15. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
Furr BJ; Tucker H
Urology; 1996 Jan; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
[TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death.
Kyprianou N; Isaacs JT
Mol Endocrinol; 1989 Oct; 3(10):1515-22. PubMed ID: 2608047
[TBL] [Abstract][Full Text] [Related]
17. TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin.
Russo P; Warner JA; Huryk R; Perez G; Heston WD
Prostate; 1994 May; 24(5):237-43. PubMed ID: 8170836
[TBL] [Abstract][Full Text] [Related]
18. Steroid-sensitive gene-1 is an androgen-regulated gene expressed in prostatic smooth muscle cells in vivo.
Marcantonio D; Chalifour LE; Alaoui-Jamali And H T Huynh MA; Alaoui-Jamali MA; Alaoui-Jamali MA; Huynh HT; Huynh HT
J Mol Endocrinol; 2001 Jun; 26(3):175-84. PubMed ID: 11357054
[TBL] [Abstract][Full Text] [Related]
19. Effects of cyproterone acetate on growth and androgen metabolism of rat ventral prostate transplants.
Thomas JA; Edwards WD; Felice PR
Endocrinol Exp; 1981 Sep; 15(3):171-9. PubMed ID: 6457737
[TBL] [Abstract][Full Text] [Related]
20. Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor.
Steinsapir J; Mora G; Muldoon TG
Biochim Biophys Acta; 1991 Aug; 1094(1):103-12. PubMed ID: 1883848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
